Showing results (41-50 of 58) with videos related to
Sort By:
Pageof 6
International Journal of Clinical Oncology|February 13, 2022
Real-world data on the efficacy and safety of adjuvant chemotherapy in Japanese patients with a high-risk of gastrointestinal stromal tumor recurrenceYuki Ushimaru, Tsuyoshi Takahashi, Kiyokazu Nakajima, et al.International Cancer Conference Journal|December 15, 2025
Conversion surgery following zolbetuximab-based chemotherapy for CLDN18.2-positive gastroesophageal junction cancerYuki Ushimaru, Kazuyoshi Yamamoto, Yoshitomo Yanagimoto, et al.BMC Surgery|May 23, 2026
Learning curve for the abdominal procedure in total robot-assisted minimally invasive esophagectomy with simultaneous cervical approach: an initial experienceTakahito Sugase, Takashi Kanemura, Norihiro Matsuura, et al.Annals of Surgical Oncology|May 1, 2025
Survival Impact of Adjuvant Nivolumab Therapy for Locally Advanced Esophageal Squamous Cell Carcinoma Treated with Neoadjuvant Chemotherapy with Docetaxel Plus 5-Fluorouracil and CisplatinTakahito Sugase, Takashi Kanemura, Norihiro Matsuura, et al.Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|September 6, 2024
Prognostic impact of dysphagia scores in patients with advanced resectable esophageal cancer who underwent radical esophagectomy after preoperative treatmentTakahito Sugase, Takashi Kanemura, Norihiro Matsuura, et al.Annals of Surgical Oncology|May 20, 2026
Clinical Outcomes of First-Line Immune Checkpoint Inhibitor-Based Therapy for Postoperative Recurrence After Adjuvant Nivolumab in Esophageal CancerTakahito Sugase, Takashi Kanemura, Norihiro Matsuura, et al.Annals of Surgical Oncology|April 14, 2026
Risk Stratification of Postoperative Recurrence After Adjuvant Nivolumab for Resected Locally Advanced Esophageal Cancer: A Real-World StudyTakahito Sugase, Takashi Kanemura, Norihiro Matsuura, et al.Esophagus : Official Journal of the Japan Esophageal Society|June 8, 2025
Safety and short-term outcomes of adjuvant nivolumab therapy at 480 mg dose every four weeks in resected esophageal cancer: a prospective cohort studyTakahito Sugase, Takashi Kanemura, Norihiro Matsuura, et al.Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|December 21, 2025
A Single-Center Retrospective Study of Conversion Surgery in Stage IV Gastric Cancer: Association With ICI-Based ChemotherapyYuki Ushimaru, Takeshi Omori, Kazuyoshi Yamamoto, et al.Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|February 26, 2025
Robotic and laparoscopic gastrectomy for gastric cancer: comparative insights into perioperative performance and three-year survival outcomesYuki Ushimaru, Takeshi Omori, Kazuyoshi Yamamoto, et al.Pageof 6